Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1069 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-03-31 (taiwannews.com.tw)
FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update | Taiwan News | Apr. 1, 2025 04:25
Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices after successfully passing all required safety testing
Read more
2025-03-28 (infomoney.com.br)
Change of CEO at Tupy generates divisions between investors and worries market
Executive exchange of the Brazilian giant metallurgical divides the opinion of investors and brings out discussions about the company's governance
Read more
2025-03-24 (braziljournal.com)
Funds question BNDESPAR and PREVI proposal to change Tupy CEO -
Managers 4th investments, Organon Capital, Charles River and Real Investor, who together add up to almost 10% of Tupy's shares, are concerned about the decision
Read more
2024-07-03 (seudinheiro.com)
700% in stocks: ex-Harvard became one of the best stock investors of the decade in Brazil
‘Stock Picker’ Camilo Marcantonio has already been recognized as the winner of the Nobel Prize in Economics
Read more
2024-01-24 (sharewise.com)
Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer, Novartis US, to its Board
Read more
2023-03-31 (reuters.com)
Charles Rivers recommends against PETA's proposal for transparency on lab monkeys
The board of Charles River Laboratories has unanimously recommended against a shareholder proposal requiring transparency on its import practices of lab monkeys, according to a regulatory filing by the U.S. contract research organization firm.
Read more
(citybiz.co)
Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Reshema Kemps-Polanco, Executive Vice President and... Read More
Read more